Recombinant adeno-associated virus (rAAV) is a leading
gene therapy
vector. However, neutralizing antibodies reduce its efficacy. Traditional
methods used to investigate antibody binding provide limited information.
Here, charge detection mass spectrometry (CD-MS) was used to investigate
the binding of monoclonal antibody ADK8 to AAV serotype 8 (AAV8).
CD-MS provides a label-free approach to antibody binding. Individual
binding events can be monitored as each event is indicated by a shift
of the antibody–antigen complex to a higher mass. Unlike other
methods, the CD-MS approach reveals the distribution of antibodies
bound on capsids, allowing AAV8 subpopulations with different affinities
to be identified. The charge state generated by the electrospray of
large ions is normally correlated with the structure, and the charge
is expected to increase when an antibody binds to the capsid exterior.
Surprisingly, binding of the first ADK8 to AAV8 causes a substantial
decrease in the charge, suggesting that the first antibody binding
event causes a significant structural change. The charge increases
for subsequent binding events. Finally, high ADK8 concentrations cause
agglutination, where ADK8 links AAV capsids to form dimers and higher
order multimers.